 
			
			
		 
			
			
		 HazMat Fee +
 HazMat Fee +
                        There will be a HazMat fee per item when shipping a dangerous goods. The HazMat fee will be charged to your UPS/DHL/FedEx collect account or added to the invoice unless the package is shipped via Ground service. Ship by air in Excepted Quantity (each bottle), which is up to 1g/1mL for class 6.1 packing group I or II, and up to 25g/25ml for all other HazMat items.
| Type | HazMat fee for 500 gram (Estimated) | 
| Excepted Quantity | USD 0.00 | 
| Limited Quantity | USD 15-60 | 
| Inaccessible (Haz class 6.1), Domestic | USD 80+ | 
| Inaccessible (Haz class 6.1), International | USD 150+ | 
| Accessible (Haz class 3, 4, 5 or 8), Domestic | USD 100+ | 
| Accessible (Haz class 3, 4, 5 or 8), International | USD 200+ | 
 
                                
                                 
                                
                                
                                    Structure of 3-Bromopyruvic acid
                                    
                                    
CAS No.: 1113-59-3
                                    
                                
 
                                 
                            *Storage: {[sel_prStorage]}
*Shipping: {[sel_prShipping]}
 
                            The BI-3802 was designed by Boehringer Ingelheim and could be obtained free of charge through the Boehringer Ingelheim open innovation portal opnMe.com, associated with its negative control.
3-Bromopyruvic acid is an inhibitor of hexokinase II with effective antitumor acitvity.
Synonyms: Bromopyruvic acid; Hexokinase II Inhibitor II, 3-BP; NSC 62343
 
                
        				4.5
        				
        					 
        					 
        					 
        					 
        					 *For Research Use Only !
        				
        				*For Research Use Only !
        			
Change View
| Size | Price | VIP Price | DE Stock US Stock | Asia Stock Global Stock | In Stock | 
| {[ item.pr_size ]} | Inquiry {[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price, item.pr_usd) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,1,item.pr_is_large_size_no_price, item.discount_usd) ]}{[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price, item.pr_usd) ]} | Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]} | {[ item.p_spot_brand_remark ]} 1-2 weeks {[ item.pr_usastock ]} In Stock Inquiry - | {[ item.p_spot_brand_remark ]} 1-2 weeks {[ item.pr_chinastock ]} {[ item.pr_remark ]} In Stock Inquiry - | Login - + | 
Please Login or Create an Account to: See VIP prices and availability
                                        
                                            Asia Stock: Ship in 3-5 business days
                                        
                                        
                                            EU Stock: ship in 0-1 business day
                                            
Global Stock: ship in 5-7 days
                                        
                                        
                                            US Stock: ship in 0-1 business day
                                            
Global Stock: ship in 5-7 days
                                        
                                    
{[ item.p_spot_brand_remark ]}
1-2weeks
Inquiry
Inquiry
{[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}
{[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price, item.pr_usd) ]}
{[ getRatePrice(item.pr_usd,1,item.mem_rate,item.pr_is_large_size_no_price, item.pr_usd) ]}
{[ item.p_spot_brand_remark ]}
1-2weeks
Inquiry
Inquiry
{[ getRatePrice(item.pr_usd,item.pr_rate,1,item.pr_is_large_size_no_price, item.vip_usd) ]}
{[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price, item.pr_usd) ]}
{[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price, item.pr_usd) ]}
In Stock
- +
Please Login or Create an Account to: See VIP prices and availability
                                        
                                            Asia Stock: Ship in 3-5 business days
                                        
                                        
                                            EU Stock: ship in 0-1 business day
                                            
Global Stock: ship in 5-7 days
                                        
                                        
                                            US Stock: ship in 0-1 business day
                                            
Global Stock: ship in 5-7 days
                                        
                                    
Search for reports by entering the product batch number.
    							Batch number can be found on the product's label following the word 'Batch'.
Search for reports by entering the product batch number.
    							Batch number can be found on the product's label following the word 'Batch'.
Search for reports by entering the product batch number.
    							Batch number can be found on the product's label following the word 'Batch'.
Search for reports by entering the product batch number.
    							Batch number can be found on the product's label following the word 'Batch'.
Search for reports by entering the product batch number.
    							Batch number can be found on the product's label following the word 'Batch'.
Design and synthesis of imidazo[1,2-a]pyridine-chalcone conjugates as antikinetoplastid agents
Agarwal, Devesh S. ; Beteck, Richard M. ; Ilbeigi, Kayhan ; Caljon, Guy ; Legoabe, Lesetja J. ;
Abstract: A library of imidazo[1,2-a]pyridine-appended chalcones were synthesized and characterized using 1H NMR,13C NMR and HRMS. The synthesized analogs were screened for their antikinetoplastid activity against Trypanosoma cruzi, Trypanosoma brucei brucei, Trypanosoma brucei rhodesiense and Leishmania infantum. The analogs were also tested for their cytotoxicity activity against human lung fibroblasts and primary mouse macrophages. Among all screened derivatives, (E)-N-(4-(3-(2-chlorophenyl)acryloyl)phenyl)imidazo[1,2-a]pyridine-2-carboxamide was found to be the most active against T. cruzi and T. b. brucei exhibiting IC50 values of 8.5 and 1.35 μM, resp. Against T. b. rhodesiense, (E)-N-(4-(3-(4-bromophenyl)acryloyl)phenyl)imidazo[1,2-a]pyridine-2-carboxamide was found to be the most active with an IC50 value of 1.13 μM. All synthesized active analogs were found to be non-cytotoxic against MRC-5 and PMM with selectivity indexes of up to more than 50.
Show More >
Keywords: antikinetoplastid ; chalcone ; drug likeliness properties ; imidazo[1,2-a]pyridine ; neglected tropical diseases (NTDs) ; Trypanosoma brucei brucei ; Trypanosoma brucei rhodesiense
Show More >
 
                        | CAS No. : | 1113-59-3 | 
| Formula : | C3H3BrO3 | 
| M.W : | 166.96 | 
| SMILES Code : | O=C(O)C(CBr)=O | 
| Synonyms : | 
                                Bromopyruvic acid; Hexokinase II Inhibitor II, 3-BP; NSC 62343
                             | 
| MDL No. : | MFCD00002587 | 
| InChI Key : | PRRZDZJYSJLDBS-UHFFFAOYSA-N | 
| Pubchem ID : | 70684 | 
| GHS Pictogram: |   | 
| Signal Word: | Danger | 
| Hazard Statements: | H314 | 
| Precautionary Statements: | P280-P305+P351+P338-P310 | 
| Class: | 8 | 
| UN#: | 3261 | 
| Packing Group: | Ⅱ | 
In Vitro:
| Cell Line | Concentration | Treated Time | Description | References | 
| Primary microglial cells | 100 µM | 24 hours | Inhibited LPS-induced NO production | J Neuroinflammation. 2021 Jun 9;18(1):129. | 
| BV-2 microglial cells | 100 µM | 24 hours | Inhibited LPS-induced NO production | J Neuroinflammation. 2021 Jun 9;18(1):129. | 
| Human erythrocytes | 3.3 µM – 2 mM | 1 minute | To study the kinetics of 3-BP transport in human erythrocytes. Results showed that 3-BP transport was linear during the initial 3-5 minutes and pH-dependent. The Km and Vm values were 0.89 mM and 0.94 mmol/(l cells x min), respectively. Transport was competitively inhibited by pyruvate and significantly inhibited by DIDS, SITS, CHC, and various polyphenols such as luteolin and quercetin. | Cell Mol Biol Lett. 2014 Jun;19(2):201-14. | 
| MDA-MB-231 | 100 µM | 1 or 24 hours | 3BP was not toxic to MDA-MB-231 cells (>90% metabolic activity retained). | Cancer Metab. 2021 Oct 14;9(1):37. | 
| BT20 | 100 µM | 1 or 24 hours | 3BP significantly reduced metabolic activity in BT20 cells (to 61% after 24-hour exposure). | Cancer Metab. 2021 Oct 14;9(1):37. | 
| Pancreatic tumor organoids | 100 µM | 12 hours | To evaluate the effect of 3-BP on the metabolism of pancreatic tumor organoids, results showed significant inhibition of organoid growth and metabolic activity | Cell Death Discov. 2024 Mar 1;10(1):106. | 
| THP-1 cells | 25-100 µM | 12 hours | Assessed the impact of 3-BP on THP-1 cell viability, found 25 μM 3-BP has no impact, 50 μM leads to 40% viability loss | Cells. 2020 May 8;9(5):1161. | 
| Yeast cells | 1-4 mM | 1-4 hours | Assessed the impact of 3-BP on wild type cell viability, found 3 h incubation with 3 mM 3-BP is not toxic for the cells | Cells. 2020 May 8;9(5):1161. | 
| Osteoarthritis fibroblast-like synoviocytes (OA FLS) | 25 µM | 24 hours | To evaluate the effect of 3-bromopyruvic acid on OA FLS proliferation, migration, and cytokine secretion. Results showed that 3-bromopyruvic acid significantly inhibited OA FLS proliferation, migration, and secretion of IL-6. | Arthritis Rheumatol. 2016 Jul;68(7):1614-26. | 
| Rheumatoid arthritis fibroblast-like synoviocytes (RA FLS) | 25 µM | 24 hours | To evaluate the effect of 3-bromopyruvic acid on RA FLS proliferation, migration, and cytokine secretion. Results showed that 3-bromopyruvic acid significantly inhibited RA FLS proliferation, migration, and secretion of IL-6 and MMP-3. | Arthritis Rheumatol. 2016 Jul;68(7):1614-26. | 
| Suit-2 cells | 50–75 µM (normoxic conditions), 12.5–25 µM (hypoxic conditions) | 24 hours | To evaluate the cytotoxicity of β-CD-3-BrPA and free 3-BrPA under normoxic and hypoxic conditions. Results showed that both drugs were more effective under hypoxic conditions in Suit-2 cells, though the difference was less pronounced compared to MiaPaCa-2 cells. | Clin Cancer Res. 2014 Dec 15;20(24):6406-17. | 
| MiaPaCa-2 cells | 50–75 µM (normoxic conditions), 12.5–25 µM (hypoxic conditions) | 24 hours | To evaluate the cytotoxicity of β-CD-3-BrPA and free 3-BrPA under normoxic and hypoxic conditions. Results showed that both drugs were more effective under hypoxic conditions in MiaPaCa-2 cells. | Clin Cancer Res. 2014 Dec 15;20(24):6406-17. | 
| SiMCT1-BT20 | 200 µM | 24 hours | SiMCT1-BT20 cells showed resistance to 3BP (72% viability vs 12% in wild type). | Cancer Metab. 2021 Oct 14;9(1):37. | 
| BT549 | 100 µM | 24 hours | 3BP rendered BT549 cells completely metabolically inactive. | Cancer Metab. 2021 Oct 14;9(1):37. | 
| SKOV3 ovarian cancer cells | 40.5 µM (IC50) | 24 hours | Evaluate the cytotoxicity of 3-BP on SKOV3 cells, results showed IC50 of 40.5 μM | Int J Mol Sci. 2021 Jan 12;22(2):709. | 
| PEO1 ovarian cancer cells | 18.7 µM (IC50) | 24 hours | Evaluate the cytotoxicity of 3-BP on PEO1 cells, results showed IC50 of 18.7 μM | Int J Mol Sci. 2021 Jan 12;22(2):709. | 
| KBM7 cells | 50 µM | 3 days | To determine the effect of MCT1 loss on 3-BrPA sensitivity, results showed MCT1-null cells were completely resistant to 3-BrPA. | Nat Genet. 2013 Jan;45(1):104-8. | 
| SKOV-3 cells | 10 µM–100 µM | 3, 6, 24 hours | Evaluate the cytotoxicity and HK2 inhibition effect of 3-BPA on SKOV-3 cells. Results showed that liposomal formulations exhibited stronger inhibitory effects and cytotoxicity at 3, 6, and 24 hours post-administration. | Int J Nanomedicine. 2015 Jul 8;10:4405-23. | 
| Breast cancer stem cells | 5–40 μg/ml | 4 hours | Evaluate the metabolic inhibition and photothermal therapy effect of 3BP on breast cancer stem cells, showing significant reduction in cell viability | Adv Healthc Mater. 2022 Apr;11(8):e2102272. | 
| F98 rodent glioma cells | 0.0001 mM–0.3 mM | 48 and 72 hours | 3-BrPA inhibited the growth and proliferation of F98 cells with IC50 values of 15.8–25.5 μM (48 hours) and 22.3–25.0 μM (72 hours). | Neuro Oncol. 2015 Jan;17(1):70-80. | 
| 9L rodent gliosarcoma cells | 0.0001 mM–0.3 mM | 48 and 72 hours | 3-BrPA inhibited the growth and proliferation of 9L cells with IC50 values of 15.8–25.5 μM (48 hours) and 22.3–25.0 μM (72 hours). | Neuro Oncol. 2015 Jan;17(1):70-80. | 
| U87 human glioblastoma cells | 0.0001 mM–0.3 mM | 48 and 72 hours | 3-BrPA inhibited the growth and proliferation of U87 cells with IC50 values of 15.8–25.5 μM (48 hours) and 22.3–25.0 μM (72 hours). | Neuro Oncol. 2015 Jan;17(1):70-80. | 
| RAW264.7 macrophages | 200 μg/mL | 48 hours | Evaluate the effect of MPB-3BP@CM NPs on macrophage polarization, results showed that MPB-3BP@CM NPs promoted macrophage polarization towards M1 phenotype | Signal Transduct Target Ther. 2024 Jun 12;9(1):158. | 
| Panc-2 cells | 20 µM and 40 µM | Significant decrease in HK2 expression level | Adv Healthc Mater. 2023 Dec;12(31):e2301815. | |
| HT29 cells | 200 μg/mL | 6 hours | Evaluate the antitumor efficacy of MPB-3BP@CM NPs on HT29 cells, results showed that MPB-3BP@CM NPs significantly inhibited tumor cell proliferation and induced apoptosis | Signal Transduct Target Ther. 2024 Jun 12;9(1):158. | 
| HCT116 cells | 200 μg/mL | 6 hours | Evaluate the antitumor efficacy of MPB-3BP@CM NPs on HCT116 cells, results showed that MPB-3BP@CM NPs significantly inhibited tumor cell proliferation and induced apoptosis | Signal Transduct Target Ther. 2024 Jun 12;9(1):158. | 
In Vivo:
| Species | Animal Model | Administration | Dosage | Frequency | Description | References | 
| F344 rats | 9L gliosarcoma allograft model | Intracranial implantation | 1%, 5%, 10%, 25%, or 50% | Single implantation | To evaluate the efficacy of 5% 3-BrPA polymer wafer in the 9L gliosarcoma model. Results showed that 5% 3-BrPA wafer significantly increased survival (median survival 18 days, P=0.0027). | Neuro Oncol. 2015 Jan;17(1):70-80. | 
| C57BL/6 female mice | Subcutaneous pancreatic cancer model | Injection | 10 mg/kg | Three times per week for 30 days | Tumor volume reduced by 60-80%, decreased HK2 expression, increased Caspase3 expression | Adv Healthc Mater. 2023 Dec;12(31):e2301815. | 
| Balb/c nude mice | 4T1 and MDA-MB-231 tumor models | Intravenous injection | 10 mg/kg | Single injection followed by photothermal therapy after 24 hours | Evaluate the metabolic inhibition and photothermal therapy effect of 3BP in vivo, showing significant tumor growth inhibition and reduced expression of CSC markers | Adv Healthc Mater. 2022 Apr;11(8):e2102272. | 
| Balb/c nude mice | 4T1 tumor model | Intravenous injection | 10 mg/mL | Single injection, observed for 48 hours | Evaluate the in vivo distribution and therapeutic effects of 3BP@PLGA-IR780, showing effective accumulation in tumor sites and inhibition of tumor growth. | J Nanobiotechnology. 2021 Dec 20;19(1):440 | 
| BALB/c nude mice | HCT116 subcutaneous tumor model | Intravenous injection | 30.0 mg/kg | Every other day for a total of three doses | Evaluate the antitumor efficacy of MPB-3BP@CM NPs in vivo, results showed that MPB-3BP@CM NPs significantly inhibited tumor growth and prolonged survival time | Signal Transduct Target Ther. 2024 Jun 12;9(1):158. | 
| Mice | K/BxN serum transfer arthritis model | Intraperitoneal injection | 5 mg/kg | Once daily for 6 days | To evaluate the effect of 3-bromopyruvic acid on arthritis severity. Results showed that 3-bromopyruvic acid significantly reduced clinical and histopathological scores of arthritis, decreased joint inflammation and cartilage damage. | Arthritis Rheumatol. 2016 Jul;68(7):1614-26. | 
| Male athymic nude mice | Orthotopic xenograft model of human pancreatic ductal adenocarcinoma (PDAC) | Intraperitoneal injection | 5 mg/kg | Daily for 4 weeks | To evaluate the antitumor efficacy and toxicity of β-CD-3-BrPA in vivo. Results showed that β-CD-3-BrPA significantly inhibited tumor growth without toxicity, while free 3-BrPA exhibited high toxicity. | Clin Cancer Res. 2014 Dec 15;20(24):6406-17. | 
| Nude mice | Subcutaneous xenograft model | 8 mg/kg | 3 weeks | To evaluate the effect of MCT1 expression on tumor sensitivity to 3-BrPA, results showed MCT1 expression enhanced tumor sensitivity to 3-BrPA. | Nat Genet. 2013 Jan;45(1):104-8. | 
| Bio Calculators | ||||
| Preparing Stock Solutions |  | 1mg | 5mg | 10mg | 
| 1 mM 5 mM 10 mM | 5.99mL 1.20mL 0.60mL | 29.95mL 5.99mL 2.99mL | 59.89mL 11.98mL 5.99mL | |
Tags: 3-Bromopyruvic acid | Bromopyruvic acid | Hexokinase II Inhibitor II | Hexokinase | Apoptosis | Autophagy | pyruvate | glycolysis | ER stress | hexokinase II inhibitor | glycolysis inhibition | ROS formation | antimicrobial | 1113-59-3
| Precautionary Statements-General | |
| Code | Phrase | 
| P101 | If medical advice is needed,have product container or label at hand. | 
| P102 | Keep out of reach of children. | 
| P103 | Read label before use | 
| Prevention | |
| Code | Phrase | 
| P201 | Obtain special instructions before use. | 
| P202 | Do not handle until all safety precautions have been read and understood. | 
| P210 | Keep away from heat/sparks/open flames/hot surfaces. - No smoking. | 
| P211 | Do not spray on an open flame or other ignition source. | 
| P220 | Keep/Store away from clothing/combustible materials. | 
| P221 | Take any precaution to avoid mixing with combustibles | 
| P222 | Do not allow contact with air. | 
| P223 | Keep away from any possible contact with water, because of violent reaction and possible flash fire. | 
| P230 | Keep wetted | 
| P231 | Handle under inert gas. | 
| P232 | Protect from moisture. | 
| P233 | Keep container tightly closed. | 
| P234 | Keep only in original container. | 
| P235 | Keep cool | 
| P240 | Ground/bond container and receiving equipment. | 
| P241 | Use explosion-proof electrical/ventilating/lighting/equipment. | 
| P242 | Use only non-sparking tools. | 
| P243 | Take precautionary measures against static discharge. | 
| P244 | Keep reduction valves free from grease and oil. | 
| P250 | Do not subject to grinding/shock/friction. | 
| P251 | Pressurized container: Do not pierce or burn, even after use. | 
| P260 | Do not breathe dust/fume/gas/mist/vapours/spray. | 
| P261 | Avoid breathing dust/fume/gas/mist/vapours/spray. | 
| P262 | Do not get in eyes, on skin, or on clothing. | 
| P263 | Avoid contact during pregnancy/while nursing. | 
| P264 | Wash hands thoroughly after handling. | 
| P265 | Wash skin thouroughly after handling. | 
| P270 | Do not eat, drink or smoke when using this product. | 
| P271 | Use only outdoors or in a well-ventilated area. | 
| P272 | Contaminated work clothing should not be allowed out of the workplace. | 
| P273 | Avoid release to the environment. | 
| P280 | Wear protective gloves/protective clothing/eye protection/face protection. | 
| P281 | Use personal protective equipment as required. | 
| P282 | Wear cold insulating gloves/face shield/eye protection. | 
| P283 | Wear fire/flame resistant/retardant clothing. | 
| P284 | Wear respiratory protection. | 
| P285 | In case of inadequate ventilation wear respiratory protection. | 
| P231 + P232 | Handle under inert gas. Protect from moisture. | 
| P235 + P410 | Keep cool. Protect from sunlight. | 
| Response | |
| Code | Phrase | 
| P301 | IF SWALLOWED: | 
| P304 | IF INHALED: | 
| P305 | IF IN EYES: | 
| P306 | IF ON CLOTHING: | 
| P307 | IF exposed: | 
| P308 | IF exposed or concerned: | 
| P309 | IF exposed or if you feel unwell: | 
| P310 | Immediately call a POISON CENTER or doctor/physician. | 
| P311 | Call a POISON CENTER or doctor/physician. | 
| P312 | Call a POISON CENTER or doctor/physician if you feel unwell. | 
| P313 | Get medical advice/attention. | 
| P314 | Get medical advice/attention if you feel unwell. | 
| P315 | Get immediate medical advice/attention. | 
| P320 | |
| P302 + P352 | IF ON SKIN: wash with plenty of soap and water. | 
| P321 | |
| P322 | |
| P330 | Rinse mouth. | 
| P331 | Do NOT induce vomiting. | 
| P332 | IF SKIN irritation occurs: | 
| P333 | If skin irritation or rash occurs: | 
| P334 | Immerse in cool water/wrap n wet bandages. | 
| P335 | Brush off loose particles from skin. | 
| P336 | Thaw frosted parts with lukewarm water. Do not rub affected area. | 
| P337 | If eye irritation persists: | 
| P338 | Remove contact lenses, if present and easy to do. Continue rinsing. | 
| P340 | Remove victim to fresh air and keep at rest in a position comfortable for breathing. | 
| P341 | If breathing is difficult, remove victim to fresh air and keep at rest in a position comfortable for breathing. | 
| P342 | If experiencing respiratory symptoms: | 
| P350 | Gently wash with plenty of soap and water. | 
| P351 | Rinse cautiously with water for several minutes. | 
| P352 | Wash with plenty of soap and water. | 
| P353 | Rinse skin with water/shower. | 
| P360 | Rinse immediately contaminated clothing and skin with plenty of water before removing clothes. | 
| P361 | Remove/Take off immediately all contaminated clothing. | 
| P362 | Take off contaminated clothing and wash before reuse. | 
| P363 | Wash contaminated clothing before reuse. | 
| P370 | In case of fire: | 
| P371 | In case of major fire and large quantities: | 
| P372 | Explosion risk in case of fire. | 
| P373 | DO NOT fight fire when fire reaches explosives. | 
| P374 | Fight fire with normal precautions from a reasonable distance. | 
| P376 | Stop leak if safe to do so. Oxidising gases (section 2.4) 1 | 
| P377 | Leaking gas fire: Do not extinguish, unless leak can be stopped safely. | 
| P378 | |
| P380 | Evacuate area. | 
| P381 | Eliminate all ignition sources if safe to do so. | 
| P390 | Absorb spillage to prevent material damage. | 
| P391 | Collect spillage. Hazardous to the aquatic environment | 
| P301 + P310 | IF SWALLOWED: Immediately call a POISON CENTER or doctor/physician. | 
| P301 + P312 | IF SWALLOWED: call a POISON CENTER or doctor/physician IF you feel unwell. | 
| P301 + P330 + P331 | IF SWALLOWED: Rinse mouth. Do NOT induce vomiting. | 
| P302 + P334 | IF ON SKIN: Immerse in cool water/wrap in wet bandages. | 
| P302 + P350 | IF ON SKIN: Gently wash with plenty of soap and water. | 
| P303 + P361 + P353 | IF ON SKIN (or hair): Remove/Take off Immediately all contaminated clothing. Rinse SKIN with water/shower. | 
| P304 + P312 | IF INHALED: Call a POISON CENTER or doctor/physician if you feel unwell. | 
| P304 + P340 | IF INHALED: Remove victim to fresh air and Keep at rest in a position comfortable for breathing. | 
| P304 + P341 | IF INHALED: If breathing is difficult, remove victim to fresh air and keep at rest in a position comfortable for breathing. | 
| P305 + P351 + P338 | IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. | 
| P306 + P360 | IF ON CLOTHING: Rinse Immediately contaminated CLOTHING and SKIN with plenty of water before removing clothes. | 
| P307 + P311 | IF exposed: call a POISON CENTER or doctor/physician. | 
| P308 + P313 | IF exposed or concerned: Get medical advice/attention. | 
| P309 + P311 | IF exposed or if you feel unwell: call a POISON CENTER or doctor/physician. | 
| P332 + P313 | IF SKIN irritation occurs: Get medical advice/attention. | 
| P333 + P313 | IF SKIN irritation or rash occurs: Get medical advice/attention. | 
| P335 + P334 | Brush off loose particles from skin. Immerse in cool water/wrap in wet bandages. | 
| P337 + P313 | IF eye irritation persists: Get medical advice/attention. | 
| P342 + P311 | IF experiencing respiratory symptoms: call a POISON CENTER or doctor/physician. | 
| P370 + P376 | In case of fire: Stop leak if safe to Do so. | 
| P370 + P378 | In case of fire: | 
| P370 + P380 | In case of fire: Evacuate area. | 
| P370 + P380 + P375 | In case of fire: Evacuate area. Fight fire remotely due to the risk of explosion. | 
| P371 + P380 + P375 | In case of major fire and large quantities: Evacuate area. Fight fire remotely due to the risk of explosion. | 
| Storage | |
| Code | Phrase | 
| P401 | |
| P402 | Store in a dry place. | 
| P403 | Store in a well-ventilated place. | 
| P404 | Store in a closed container. | 
| P405 | Store locked up. | 
| P406 | Store in corrosive resistant/ container with a resistant inner liner. | 
| P407 | Maintain air gap between stacks/pallets. | 
| P410 | Protect from sunlight. | 
| P411 | |
| P412 | Do not expose to temperatures exceeding 50 oC/ 122 oF. | 
| P413 | |
| P420 | Store away from other materials. | 
| P422 | |
| P402 + P404 | Store in a dry place. Store in a closed container. | 
| P403 + P233 | Store in a well-ventilated place. Keep container tightly closed. | 
| P403 + P235 | Store in a well-ventilated place. Keep cool. | 
| P410 + P403 | Protect from sunlight. Store in a well-ventilated place. | 
| P410 + P412 | Protect from sunlight. Do not expose to temperatures exceeding 50 oC/122oF. | 
| P411 + P235 | Keep cool. | 
| Disposal | |
| Code | Phrase | 
| P501 | Dispose of contents/container to ... | 
| P502 | Refer to manufacturer/supplier for information on recovery/recycling | 
| Physical hazards | |
| Code | Phrase | 
| H200 | Unstable explosive | 
| H201 | Explosive; mass explosion hazard | 
| H202 | Explosive; severe projection hazard | 
| H203 | Explosive; fire, blast or projection hazard | 
| H204 | Fire or projection hazard | 
| H205 | May mass explode in fire | 
| H220 | Extremely flammable gas | 
| H221 | Flammable gas | 
| H222 | Extremely flammable aerosol | 
| H223 | Flammable aerosol | 
| H224 | Extremely flammable liquid and vapour | 
| H225 | Highly flammable liquid and vapour | 
| H226 | Flammable liquid and vapour | 
| H227 | Combustible liquid | 
| H228 | Flammable solid | 
| H229 | Pressurized container: may burst if heated | 
| H230 | May react explosively even in the absence of air | 
| H231 | May react explosively even in the absence of air at elevated pressure and/or temperature | 
| H240 | Heating may cause an explosion | 
| H241 | Heating may cause a fire or explosion | 
| H242 | Heating may cause a fire | 
| H250 | Catches fire spontaneously if exposed to air | 
| H251 | Self-heating; may catch fire | 
| H252 | Self-heating in large quantities; may catch fire | 
| H260 | In contact with water releases flammable gases which may ignite spontaneously | 
| H261 | In contact with water releases flammable gas | 
| H270 | May cause or intensify fire; oxidizer | 
| H271 | May cause fire or explosion; strong oxidizer | 
| H272 | May intensify fire; oxidizer | 
| H280 | Contains gas under pressure; may explode if heated | 
| H281 | Contains refrigerated gas; may cause cryogenic burns or injury | 
| H290 | May be corrosive to metals | 
| Health hazards | |
| Code | Phrase | 
| H300 | Fatal if swallowed | 
| H301 | Toxic if swallowed | 
| H302 | Harmful if swallowed | 
| H303 | May be harmful if swallowed | 
| H304 | May be fatal if swallowed and enters airways | 
| H305 | May be harmful if swallowed and enters airways | 
| H310 | Fatal in contact with skin | 
| H311 | Toxic in contact with skin | 
| H312 | Harmful in contact with skin | 
| H313 | May be harmful in contact with skin | 
| H314 | Causes severe skin burns and eye damage | 
| H315 | Causes skin irritation | 
| H316 | Causes mild skin irritation | 
| H317 | May cause an allergic skin reaction | 
| H318 | Causes serious eye damage | 
| H319 | Causes serious eye irritation | 
| H320 | Causes eye irritation | 
| H330 | Fatal if inhaled | 
| H331 | Toxic if inhaled | 
| H332 | Harmful if inhaled | 
| H333 | May be harmful if inhaled | 
| H334 | May cause allergy or asthma symptoms or breathing difficulties if inhaled | 
| H335 | May cause respiratory irritation | 
| H336 | May cause drowsiness or dizziness | 
| H340 | May cause genetic defects | 
| H341 | Suspected of causing genetic defects | 
| H350 | May cause cancer | 
| H351 | Suspected of causing cancer | 
| H360 | May damage fertility or the unborn child | 
| H361 | Suspected of damaging fertility or the unborn child | 
| H361d | Suspected of damaging the unborn child | 
| H362 | May cause harm to breast-fed children | 
| H370 | Causes damage to organs | 
| H371 | May cause damage to organs | 
| H372 | Causes damage to organs through prolonged or repeated exposure | 
| H373 | May cause damage to organs through prolonged or repeated exposure | 
| Environmental hazards | |
| Code | Phrase | 
| H400 | Very toxic to aquatic life | 
| H401 | Toxic to aquatic life | 
| H402 | Harmful to aquatic life | 
| H410 | Very toxic to aquatic life with long-lasting effects | 
| H411 | Toxic to aquatic life with long-lasting effects | 
| H412 | Harmful to aquatic life with long-lasting effects | 
| H413 | May cause long-lasting harmful effects to aquatic life | 
| H420 | Harms public health and the environment by destroying ozone in the upper atmosphere | 
Sorry,this product has been discontinued.
Home
* Country/Region
* Quantity Required :
* Cat. No.:
* CAS No :
* Product Name :
* Additional Information :
Total Compounds: mg
The concentration of the dissolution solution you need to prepare is mg/mL

